1. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study. (February 2023) Authors: Liu, Zhigang; Le, Kaixing; Zhou, Xin; Alexander, James L; Lin, Simeng; Bewshea, Claire; Chanchlani, Neil; Nice, Rachel; McDonald, Timothy J; Lamb, Christopher A; Sebastian, Shaji; Kok, Klaartje; Lees, Charlie W; Hart, Ailsa L; Pollok, Richard C; Boyton, Rosemary J; Altmann, Daniel M; Pollock, Kat... Journal: Lancet gastroenterology and hepatology Issue: Volume 8:Number 2(2023) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Postoperative continuous positive airway pressure to prevent pneumonia, re-intubation, and death after major abdominal surgery (PRISM): a multicentre, open-label, randomised, phase 3 trial. Issue 11 (November 2021) Authors: Pearse, Rupert; Ranieri, Marco; Abbott, Tom; Pakats, Mari-Liis; Piervincenzi, Edoardo; Patel, Akshaykumar; Kahan, Brennan; Rhodes, Andrew; Dias, Priyanthi; Hewson, Russell; Jammer, Ib; Chew, Michelle; Aldecoa, Cesar; Rodseth, Reitze; Biccard, Bruce; Stephens, Tim; Payne, Sara; Hepworth, David; Pi... Journal: Lancet Issue: Volume 9:Issue 11(2021) Page Start: 1221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗